EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lys694Arg polymorphism leads to blunted responses to LPS by interfering TLR4 with recruitment of MyD88

Yajie Yang, Yan Hu, Yile Zhou, Tao Liang, Haihong Tang, Huihui Ju, Qiqing Shi, Hao Fang iD

Innate Immunity · 2021-08 · 27 (6) · 483-492

DOI: 10.1177/1753425920927479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innate Immunity, online erschienen am 08.06.2020. Verfasst von Yajie Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Jinshan Hospital, Fudan University, PR China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TLR4 polymorphisms such as Asp299Gly and Thr399Ile related to Gram-negative sepsis have been reported to result in significantly blunted responsiveness to LPS. Our study group previously screened other TLR4 polymorphic variants by checking the NF-κB activation in comparison to wild type (WT) TLR4 in human embryonic kidney 293T cells. In this study, we found that the Lys694Arg (K694R) polymorphism reduced the activation of NF-κB, and the production of downstream inflammatory factors IL-1, TNF-α and IL-6, representing the K694R polymorphism, led to blunted responsiveness to LPS. Then, we examined the influence of the K694R polymorphism on total and cell-surface TLR4 expression by Western blotting and flow cytometry, respectively, but observed no differences between the K694R polymorphism and WT TLR4. We also used co-immunoprecipitation to determine the interaction of the K694R polymorphism and WT TLR4 with their co-receptor myeloid differentiation factor 2 (MD2) and their downstream signal adaptor MyD88. We found that K694R reduced the recruitment of MyD88 in TLR4 signalling but had no impact on the interaction with MD2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineHEK293 CellsHumansInterleukin-1Interleukin-6Kidney NeoplasmsLipopolysaccharidesLysineMutationMyeloid Differentiation Factor 88NF-kappa BPolymorphism, GeneticSignal TransductionToll-Like Receptor 4Tumor Necrosis Factor-alpha

Stichwörter der Autor:innen

CytokinesLys694ArgMyD88NF-κBTLR4

Substanzen

Interleukin-1Interleukin-6LipopolysaccharidesMyeloid Differentiation Factor 88NF-kappa BToll-Like Receptor 4Tumor Necrosis Factor-alphaArginineLysine

Autor:innen und Institutionen

  • Department of Anaesthesiology, Jinshan Hospital, Fudan University, PR China.
  • Department of Anaesthesiology, Zhongshan Hospital, Fudan University, PR China.
  • Department of Anaesthesiology, Minhang Branch, Zhongshan Hospital, Fudan University, PR China.

ORCID-Profile: Hao Fang

Zitieren

APA

Yang, Y., Hu, Y., Zhou, Y., Liang, T., Tang, H., Ju, H., Shi, Q., & Fang, H. (2021). Lys694Arg polymorphism leads to blunted responses to LPS by interfering TLR4 with recruitment of MyD88. Innate Immunity, 27(6), 483-492. https://doi.org/10.1177/1753425920927479

Vancouver

Yang Y, Hu Y, Zhou Y, Liang T, Tang H, Ju H, et al. Lys694Arg polymorphism leads to blunted responses to LPS by interfering TLR4 with recruitment of MyD88. Innate Immunity. 2021;27(6):483-492. doi:10.1177/1753425920927479

BibTeX
@article{Yang2021,
  author = {Yang, Yajie and Hu, Yan and Zhou, Yile and Liang, Tao and Tang, Haihong and Ju, Huihui and Shi, Qiqing and Fang, Hao},
  title = {Lys694Arg polymorphism leads to blunted responses to LPS by interfering TLR4 with recruitment of MyD88},
  journal = {Innate Immunity},
  year = {2021},
  volume = {27},
  number = {6},
  pages = {483--492},
  doi = {10.1177/1753425920927479}
}
Kostenlos starten →